Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Impact BioMedical Inc.

    AMEX: IBO · Real-Time Price · USD
    0.65
    -0.02 (-3.62%)
    At close: Jul 03, 2025, 3:59 PM
    0.63
    -2.79%
    After-hours: Jul 03, 2025, 04:59 PM EDT

    Impact BioMedical Statistics

    Share Statistics

    Impact BioMedical has 12.09M shares outstanding. The number of shares has increased by 5.11% in one year.

    Shares Outstanding

    n/a
    		 12.09M

    Shares Change (YoY)

    n/a
    		 5.11%

    Shares Change (QoQ)

    n/a
    		 -39.87%

    Owned by Institutions (%)

    n/a
    		 0.03%

    Shares Floating

    n/a
    		 11.98M

    Failed to Deliver (FTD) Shares

    n/a
    		 739

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 254.22K, so 2.1% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 254.22K

    Short % of Shares Out

    n/a
    		 2.1%

    Short % of Float

    n/a
    		 3.8%

    Short Ratio (days to cover)

    n/a
    		 1.12

    Valuation Ratios

    The PE ratio is -8805.66 and the forward PE ratio is null. Impact BioMedical's PEG ratio is -106.29.

    PE Ratio

    n/a
    		 -8805.66

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 86314.58

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 23440.83

    P/FCF Ratio

    n/a
    		 -20869.09

    PEG Ratio

    n/a
    		 -106.29
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Impact BioMedical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.6, with a Debt / Equity ratio of 0.44.

    Current Ratio

    n/a
    		 1.6

    Quick Ratio

    n/a
    		 1.6

    Debt / Equity

    n/a
    		 0.44

    Debt / EBITDA

    n/a
    		 -0.38

    Debt / FCF

    n/a
    		 -0.39

    Interest Coverage

    n/a
    		 7.34

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $535,402

    Profits Per Employee

    n/a
    		 $-5,248,101

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0.17

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -59.8K

    Effective Tax Rate

    n/a
    		 0.57%

    Stock Price Statistics

    The stock price has increased by -99.83% in the last 52 weeks. The beta is 6.75, so Impact BioMedical's price volatility has been higher than the market average.

    Beta

    n/a
    		 6.75

    52-Week Price Change

    n/a
    		 -99.83%

    50-Day Moving Average

    n/a
    		 0.56

    200-Day Moving Average

    n/a
    		 1.5

    Relative Strength Index (RSI)

    n/a
    		 49.97

    Average Volume (20 Days)

    n/a
    		 13,495,465

    Income Statement

    In the last 12 months, Impact BioMedical had revenue of 1.07M and earned -10.5M in profits. Earnings per share was -0.06.

    Revenue

    n/a
    		 1.07M

    Gross Profit

    n/a
    		 1.07M

    Operating Income

    n/a
    		 497.15K

    Net Income

    n/a
    		 -10.5M

    EBITDA

    n/a
    		 -4.61M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.06
    Full Income Statement

    Balance Sheet

    The company has 726.05K in cash and 1.74M in debt, giving a net cash position of -1.01M.

    Cash & Cash Equivalents

    n/a
    		 726.05K

    Total Debt

    n/a
    		 1.74M

    Net Cash

    n/a
    		 -1.01M

    Retained Earnings

    n/a
    		 -22.74M

    Total Assets

    n/a
    		 5.87M

    Working Capital

    n/a
    		 -552.12K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.33M and capital expenditures -95.68K, giving a free cash flow of -4.43M.

    Operating Cash Flow

    n/a
    		 -4.33M

    Capital Expenditures

    n/a
    		 -95.68K

    Free Cash Flow

    n/a
    		 -4.43M

    FCF Per Share

    n/a
    		 -0.02
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 46.43% and -980.22%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 46.43%

    Pretax Margin

    n/a
    		 -980.22%

    Profit Margin

    n/a
    		 -980.22%

    EBITDA Margin

    n/a
    		 -430.27%

    EBIT Margin

    n/a
    		 46.43%

    FCF Margin

    n/a
    		 -413.6%

    Dividends & Yields

    IBO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for IBO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.73

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist